Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BeyondSpring
Biotech
Eisai plants molecular glue SEED with $1.5B biobucks deal
Japan’s Eisai has signed a $1.5 billion biobucks pact with SEED Therapeutics for undisclosed neurodegeneration and oncology targets.
James Waldron
Aug 6, 2024 10:24am
BeyondSpring axes 35% of US staff after November drug rejection
Jan 12, 2022 10:05am
BeyondSpring lurches down as FDA rejects plinabulin
Dec 3, 2021 7:45am
BeyondSpring, flying high from phase 3 success, inks cancer deal
Aug 27, 2021 8:20am
BeyondSpring lands on Nasdaq with $54M IPO
Mar 9, 2017 10:44am
